Scopus Asset Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-145,000
Closed -$15.7M 250
2018
Q2
$15.7M Buy
+145,000
New +$15.6M 0.15% 171
2018
Q1
Sell
-190,000
Closed -$22.3M 300
2017
Q4
$22.3M Buy
+190,000
New +$19.7M 0.21% 141
2016
Q3
Sell
-1,090
Closed -$116K 203
2016
Q2
$116K Buy
+1,090
New +$112K ﹤0.01% 205
2015
Q4
Sell
-504,515
Closed -$45.7M 151
2015
Q3
$45.7M Buy
504,515
+27,156
+6% +$2.72M 1.27% 25
2015
Q2
$50.7M Buy
+477,359
New +$47.9M 0.87% 27

Other funds holding CRI

Scopus Asset Management's CRI Position: Q3 2018 in Review

Scopus Asset Management sold out of Carter's (CRI) in Q3 2018, closing a stake of 145,000 shares — an estimated $15.7M sold.

Scopus Asset Management first reported a position in CRI in Q2 2015 and held it in 5 quarters. The position peaked at $50.7M in Q2 2015. 332 funds tracked by Wall St. Rank hold CRI as of Q3 2018.

  • Scopus Asset Management reported no remaining Carter's position as of Q3 2018 after selling out during the quarter.
  • Scopus Asset Management sold 145,000 Carter's shares in Q3 2018, an estimated $15.7M.
  • Scopus Asset Management first reported a position in Carter's in Q2 2015 and held it in 5 quarters.
  • Scopus Asset Management's Carter's position peaked at $50.7M in Q2 2015.
  • 332 funds tracked by Wall St. Rank held Carter's as of Q3 2018.

Based on Scopus Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.